Raymond James Financial Services Advisors’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-599
Closed -$5K 2870
2018
Q2
$5K Hold
599
﹤0.01% 2762
2018
Q1
$10K Buy
599
+43
+8% +$795 ﹤0.01% 2526
2017
Q4
$10K Hold
556
﹤0.01% 2521
2017
Q3
$13K Hold
556
﹤0.01% 2536
2017
Q2
$15K Hold
556
﹤0.01% 2488
2017
Q1
$12K Hold
556
﹤0.01% 2406
2016
Q4
$12K Buy
+556
New +$14.8K ﹤0.01% 2325

Other funds holding NNVC

Raymond James Financial Services Advisors's NNVC Position: Q3 2018 in Review

Raymond James Financial Services Advisors sold out of NanoViricides (NNVC) in Q3 2018, closing a stake of 599 shares — an estimated $5K sold.

Raymond James Financial Services Advisors first reported a position in NNVC in Q4 2016 and held it in 7 quarters. The position peaked at $15K in Q2 2017. 43 funds tracked by Wall St. Rank hold NNVC as of Q3 2018.

  • Raymond James Financial Services Advisors reported no remaining NanoViricides position as of Q3 2018 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 599 NanoViricides shares in Q3 2018, an estimated $5K.
  • Raymond James Financial Services Advisors first reported a position in NanoViricides in Q4 2016 and held it in 7 quarters.
  • Raymond James Financial Services Advisors's NanoViricides position peaked at $15K in Q2 2017.
  • 43 funds tracked by Wall St. Rank held NanoViricides as of Q3 2018.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.